FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047511834> ?p ?o ?g. }

• W2047511834 endingPage "71" @default.
• W2047511834 startingPage "66" @default.
• W2047511834 abstract "<b><i>Background:</i></b> Inflammatory mechanisms have been implicated in the pathogenesis of Alzheimer’s disease (AD) and may be mediated via the cyclo-oxygenase–2 enzyme. This study sought to evaluate the effect of rofecoxib, a nonsteroidal anti-inflammatory drug that selectively inhibits cyclo-oxygenase–2, in slowing the progression of dementia in patients with established AD. <b><i>Methods:</i></b> A double-blinded, multicenter trial was conducted in which 692 patients with mild or moderate AD aged 50 years or older were randomly assigned to receive 25 mg rofecoxib or placebo daily for 12 months. The key efficacy measures were mean change from baseline at month 12 on the cognitive subscale of the AD Assessment Scale (ADAS-cog) and score on the Clinician’s Interview Based Impression of Change with caregiver input (CIBIC+). <b><i>Results:</i></b> Four hundred eighty-one patients (70%) completed assessments and remained on treatment at 12 months. No significant differences between treatments were found on the mean change from baseline error score for the ADAS-cog (rofecoxib = 4.84; placebo = 5.44; difference = −0.60) or mean score on the CIBIC+ (rofecoxib = 4.90; placebo = 4.87; difference = 0.03) over 12 months. This result persisted after adjusting for severity of dementia at baseline, presence of the <i>APOE</i>-ε4 allele, and donepezil use. Secondary analyses did not reveal any significant differences on any other measures. <b><i>Conclusion:</i></b> The failure of selective cyclo-oxygenase–2 inhibition to slow the progression of AD may indicate either that the disease process is too advanced to modify in patients with established dementia or that cyclo-oxygenase–2 does not play a significant role in the pathogenesis of the disorder." @default.
• W2047511834 created "2016-06-24" @default.
• W2047511834 creator A5021135644 @default.
• W2047511834 creator A5024413353 @default.
• W2047511834 creator A5025640273 @default.
• W2047511834 creator A5035049807 @default.
• W2047511834 creator A5058008362 @default.
• W2047511834 creator A5063630764 @default.
• W2047511834 creator A5077788485 @default.
• W2047511834 creator A5078505933 @default.
• W2047511834 date "2004-01-12" @default.
• W2047511834 modified "2023-10-11" @default.
• W2047511834 title "Rofecoxib: No effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study" @default.
• W2047511834 cites W1847168837 @default.
• W2047511834 cites W1953027527 @default.
• W2047511834 cites W1972954420 @default.
• W2047511834 cites W1987407100 @default.
• W2047511834 cites W1998213501 @default.
• W2047511834 cites W2000795486 @default.
• W2047511834 cites W2008966172 @default.
• W2047511834 cites W2012652085 @default.
• W2047511834 cites W2028950040 @default.
• W2047511834 cites W2032640715 @default.
• W2047511834 cites W2038410983 @default.
• W2047511834 cites W2042690206 @default.
• W2047511834 cites W2042706422 @default.
• W2047511834 cites W2044750065 @default.
• W2047511834 cites W2046454316 @default.
• W2047511834 cites W2057679568 @default.
• W2047511834 cites W2068477037 @default.
• W2047511834 cites W2083556882 @default.
• W2047511834 cites W2087028773 @default.
• W2047511834 cites W2113690827 @default.
• W2047511834 cites W2117227343 @default.
• W2047511834 cites W2123366546 @default.
• W2047511834 cites W2137103253 @default.
• W2047511834 cites W2149954869 @default.
• W2047511834 cites W2156220037 @default.
• W2047511834 cites W2330496155 @default.
• W2047511834 cites W2980623457 @default.
• W2047511834 doi "https://doi.org/10.1212/wnl.62.1.66" @default.
• W2047511834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14718699" @default.
• W2047511834 hasPublicationYear "2004" @default.
• W2047511834 type Work @default.
• W2047511834 sameAs 2047511834 @default.
• W2047511834 citedByCount "372" @default.
• W2047511834 countsByYear W20475118342012 @default.
• W2047511834 countsByYear W20475118342013 @default.
• W2047511834 countsByYear W20475118342014 @default.
• W2047511834 countsByYear W20475118342015 @default.
• W2047511834 countsByYear W20475118342016 @default.
• W2047511834 countsByYear W20475118342017 @default.
• W2047511834 countsByYear W20475118342018 @default.
• W2047511834 countsByYear W20475118342019 @default.
• W2047511834 countsByYear W20475118342020 @default.
• W2047511834 countsByYear W20475118342021 @default.
• W2047511834 countsByYear W20475118342022 @default.
• W2047511834 countsByYear W20475118342023 @default.
• W2047511834 crossrefType "journal-article" @default.
• W2047511834 hasAuthorship W2047511834A5021135644 @default.
• W2047511834 hasAuthorship W2047511834A5024413353 @default.
• W2047511834 hasAuthorship W2047511834A5025640273 @default.
• W2047511834 hasAuthorship W2047511834A5035049807 @default.
• W2047511834 hasAuthorship W2047511834A5058008362 @default.
• W2047511834 hasAuthorship W2047511834A5063630764 @default.
• W2047511834 hasAuthorship W2047511834A5077788485 @default.
• W2047511834 hasAuthorship W2047511834A5078505933 @default.
• W2047511834 hasConcept C126322002 @default.
• W2047511834 hasConcept C142724271 @default.
• W2047511834 hasConcept C168563851 @default.
• W2047511834 hasConcept C181199279 @default.
• W2047511834 hasConcept C185592680 @default.
• W2047511834 hasConcept C204787440 @default.
• W2047511834 hasConcept C27081682 @default.
• W2047511834 hasConcept C2777427615 @default.
• W2047511834 hasConcept C2778582115 @default.
• W2047511834 hasConcept C2779134260 @default.
• W2047511834 hasConcept C2779281540 @default.
• W2047511834 hasConcept C2779483572 @default.
• W2047511834 hasConcept C2779689624 @default.
• W2047511834 hasConcept C2780904820 @default.
• W2047511834 hasConcept C502032728 @default.
• W2047511834 hasConcept C535046627 @default.
• W2047511834 hasConcept C55493867 @default.
• W2047511834 hasConcept C71924100 @default.
• W2047511834 hasConcept C90924648 @default.
• W2047511834 hasConceptScore W2047511834C126322002 @default.
• W2047511834 hasConceptScore W2047511834C142724271 @default.
• W2047511834 hasConceptScore W2047511834C168563851 @default.
• W2047511834 hasConceptScore W2047511834C181199279 @default.
• W2047511834 hasConceptScore W2047511834C185592680 @default.
• W2047511834 hasConceptScore W2047511834C204787440 @default.
• W2047511834 hasConceptScore W2047511834C27081682 @default.
• W2047511834 hasConceptScore W2047511834C2777427615 @default.
• W2047511834 hasConceptScore W2047511834C2778582115 @default.
• W2047511834 hasConceptScore W2047511834C2779134260 @default.
• W2047511834 hasConceptScore W2047511834C2779281540 @default.
• W2047511834 hasConceptScore W2047511834C2779483572 @default.

• next